Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
Yukio Sassa, Yasuaki HataDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanAbstract: Age-related macular degeneration (AMD) complications are the leading cause of severe vision loss among the aging population in the many western countries. The introdu...
Saved in:
Main Authors: | Yukio Sassa, Yasuaki Hata |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/b76f7850d4434736b3bbd437ed9e89ab |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of antivascular endothelial growth factor for diabetic macular edema
by: Rushmia Karim, et al.
Published: (2010) -
Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
by: Carreras A, et al.
Published: (2012) -
Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
by: Asahi MG, et al.
Published: (2017) -
Treatment of retinal pigment epithelial detachment with antiangiogenic therapy
by: Luis Arias
Published: (2010) -
Emerging roles for antiangiogenesis factors in management of ocular disease
by: Saeed MU, et al.
Published: (2013)